By definition, hepatogenous diabetes is directly caused by loss of liver function, implying that it develops after cirrhosis onset. Therefore, it should be distinguished from type 2 diabetes developing before cirrhosis onset, in which specific causes of liver disease play a major role, in addition to traditional risk factors. Currently, although hepatogenous diabetes shows distinct pathophysiological and clinical features, it is not considered as an autonomous entity. Recent evidence suggests that the failing liver exerts an independent "toxic" effect on pancreatic islets resulting in β-cell dysfunction. Moreover, patients with hepatogenous diabetes usually present with normal fasting glucose and haemoglobin A1c levels and abnormal response to an oral glucose tolerance test, which is therefore required for diagnosis. This article discusses the need to separate hepatogenous diabetes from type 2 diabetes occurring in subjects with chronic liver disease and to identify individuals suffering from this condition for prognostic and therapeutic purposes.

Hepatogenous diabetes. Is it time to separate it from type 2 diabetes? / Orsi, Emanuela; Grancini, Valeria; Menini, Stefano; Aghemo, Alessio; Pugliese, Giuseppe. - In: LIVER INTERNATIONAL. - ISSN 1478-3223. - STAMPA. - 37:7(2017), pp. 950-962. [10.1111/liv.13337]

Hepatogenous diabetes. Is it time to separate it from type 2 diabetes?

MENINI, Stefano;PUGLIESE, Giuseppe
Ultimo
2017

Abstract

By definition, hepatogenous diabetes is directly caused by loss of liver function, implying that it develops after cirrhosis onset. Therefore, it should be distinguished from type 2 diabetes developing before cirrhosis onset, in which specific causes of liver disease play a major role, in addition to traditional risk factors. Currently, although hepatogenous diabetes shows distinct pathophysiological and clinical features, it is not considered as an autonomous entity. Recent evidence suggests that the failing liver exerts an independent "toxic" effect on pancreatic islets resulting in β-cell dysfunction. Moreover, patients with hepatogenous diabetes usually present with normal fasting glucose and haemoglobin A1c levels and abnormal response to an oral glucose tolerance test, which is therefore required for diagnosis. This article discusses the need to separate hepatogenous diabetes from type 2 diabetes occurring in subjects with chronic liver disease and to identify individuals suffering from this condition for prognostic and therapeutic purposes.
2017
cirrhosis; hepatogenous diabetes; insulin resistance; orthotopic liver transplant; β-cell dysfunction; hepatology
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Hepatogenous diabetes. Is it time to separate it from type 2 diabetes? / Orsi, Emanuela; Grancini, Valeria; Menini, Stefano; Aghemo, Alessio; Pugliese, Giuseppe. - In: LIVER INTERNATIONAL. - ISSN 1478-3223. - STAMPA. - 37:7(2017), pp. 950-962. [10.1111/liv.13337]
File allegati a questo prodotto
File Dimensione Formato  
Orsi_Hepatogenous_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 561.02 kB
Formato Adobe PDF
561.02 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/947932
Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 55
  • ???jsp.display-item.citation.isi??? 44
social impact